Concepedia
Statistics
Publications
17
Citations
2.6K
H-Index
16
Active since
1998
Affiliations
Eli Lilly (United States)(Current)
McLean Hospital
Harvard University
University of Minnesota Medical Center
The University of Texas at San Antonio Health Science Center
Daniel Lin is an author at Eli Lilly (United States) specializing in psychiatry, psychopharmacology, and pharmacotherapy.
Publications per year
1998–2019
The Bias Blind Spot: Perceptions of Bias in Self Versus Others
Emily Pronin, Daniel Lin, Lee Ross · Personality and Social Psychology Bulletin · 2002 · 1.3K citations
Social Sciences, Psychology, Social Psychology +16
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Mauricio Tohen, Ludmila Kryzhanovskaya, Gabrielle A. Carlson et al. · American Journal of Psychiatry · 2007 · 316 citations
Medicine, Pharmacotherapy, Psychiatry +16
Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
John M. Kane, Holland C. Detke, Dieter Naber et al. · American Journal of Psychiatry · 2009 · 197 citations
Pharmacy, Pharmacotherapy, Psychiatry +16
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study
S. Charles Schulz, Mary C. Zanarini, Anthony Bateman et al. · The British Journal of Psychiatry · 2008 · 123 citations
Medicine, Pharmacotherapy, Psychiatry +10
An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
John Lauriello, Tim Lambert, Scott W. Andersen et al. · The Journal of Clinical Psychiatry · 2008 · 119 citations
Pharmacy, Pharmacotherapy, Psychiatry +17
1–5 of 17